Skip to main content

Craig Eagle

Equibles does not estimate personal net worth.

About Craig Eagle

Craig Eagle is recorded as Board Member at OS Therapies Inc (OSTX). The newest filing on record that lists Craig Eagle as Board Member at OS Therapies Inc (OSTX) is dated July 24, 2026. OS Therapies Inc reported in an 8-K filed September 9, 2026 that Craig Eagle was appointed director, effective September 9, 2026. Telomir Pharmaceuticals, Inc. reported in an 8-K filed November 20, 2025 that Craig Eagle resigned as member of the Board of Directors, effective November 14, 2025. OS Therapies Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at OS Therapies Inc includes Paul A. Romness (CEO and Board Member), Christopher P. Acevedo (CFO), Francis (Frank) Knuettel II (CFO) and 7 others.

“The stockholders approved the election of each of the director nominees to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, which required the affirmative vote of the majority of shares of stock present, in person or by proxy, and entitled to vote.”
OS Therapies Inc Form 8-K, filed September 9, 2026 · Read the filing
“On November 14, 2025, Craig Eagle, a member of the Board of Directors (the "Board") of Telomir Pharmaceuticals Inc. (the "Company"), resigned from the Board, effective immediately.”
Telomir Pharmaceuticals, Inc. Form 8-K, filed November 20, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at OS Therapies Inc

Recent activity